Rosanna Lagos

Motavizumab Treatment of Infants Hospitalized With Respiratory Syncytial Virus Infection Does Not Decrease Viral Load or Severity of Illness

Octavio Ramilo, Rosanna Lagos, Xavier Sáez‐Llorens et al. · The Pediatric Infectious Disease Journal · 2013 · 87 citations

Safety and Immunogenicity of Low and High Doses of Trivalent Live Cold‐Adapted Influenza Vaccine Administered Intranasally as Drops or Spray to Healthy Children

James C. King, Rosanna Lagos, David I. Bernstein et al. · The Journal of Infectious Diseases · 1998 · 78 citations · Full text

Age-specific prevalence of antibodies to hepatitis A in Santiago, Chile: risk factors and shift in age of infection among children and young adults.

Alan Fix, Oriana San Martin, Lisa Gallicchio et al. · American Journal of Tropical Medicine and Hygiene · 2002 · 66 citations

Young Adults, Epidemiologic Research, Hepatitis B +16

SAFETY AND ANTIVIRAL ACTIVITY OF MOTAVIZUMAB, A RESPIRATORY SYNCYTIAL VIRUS (RSV)–SPECIFIC HUMANIZED MONOCLONAL ANTIBODY, WHEN ADMINISTERED TO RSV-INFECTED CHILDREN

Rosanna Lagos, John P. DeVincenzo, Alma Muñoz et al. · The Pediatric Infectious Disease Journal · 2009 · 56 citations

Respiratory Syncytial Virus, Respiratory Virus Immunity, Respiratory Diseases +14

Further consideration of the clonal nature of Salmonella typhi: evaluation of molecular and clinical characteristics of strains from Indonesia and Peru

Augusto A. Franco, Orin S. Levine, Rosanna Lagos et al. · Journal of Clinical Microbiology · 1992 · 32 citations · Full text

Clonal Nature, Envelope Protein Patterns, Pathogen Detection +14